Get started
NRX Pharmaceuticals, Inc.NRX Pharmaceuticals, Inc.NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Minds

NRXPW chart

Key stats

Market capitalization
‪27.61 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.1849USD
Net income (FY)
‪−30.15 M‬USD
Revenue (FY)
—
Shares float
‪7.02 M‬
Beta (1Y)
−1.28

About NRX Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Stephen H. Willard
Headquarters
Wilmington
Website
nrxpharma.com
Founded
2017
FIGI
BBG00JCWDKV1
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.